PATIENT_PLAN_DIRECT_LIMIT - Accounts


Company Registration No. 06905458 (England and Wales)
PATIENT PLAN DIRECT LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2020
PAGES FOR FILING WITH REGISTRAR
PATIENT PLAN DIRECT LIMITED
CONTENTS
Page
Balance sheet
1 - 2
Notes to the financial statements
3 - 10
PATIENT PLAN DIRECT LIMITED
BALANCE SHEET
AS AT 31 DECEMBER 2020
31 December 2020
- 1 -
2020
2019
Notes
£
£
£
£
Fixed assets
Intangible assets
5
186,853
46,912
Tangible assets
6
29,659
40,310
216,512
87,222
Current assets
Debtors
7
44,699
32,723
Cash at bank and in hand
62,757
73,898
107,456
106,621
Creditors: amounts falling due within one year
8
(237,179)
(128,613)
Net current liabilities
(129,723)
(21,992)
Total assets less current liabilities
86,789
65,230
Creditors: amounts falling due after more than one year
9
(50,000)
-
0
Provisions for liabilities
3,069
3,069
Net assets
39,858
68,299
Capital and reserves
Called up share capital
5,000
5,000
Profit and loss reserves
34,858
63,299
Total equity
39,858
68,299
PATIENT PLAN DIRECT LIMITED
BALANCE SHEET (CONTINUED)
AS AT 31 DECEMBER 2020
31 December 2020
- 2 -

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

For the financial year ended 31 December 2020 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the board of directors and authorised for issue on 9 March 2021 and are signed on its behalf by:
C Broadbent
Director
Company Registration No. 06905458
PATIENT PLAN DIRECT LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2020
- 3 -
1
Accounting policies
Company information

Patient Plan Direct Limited is a private company limited by shares incorporated in England and Wales. The registered office is Glebe Business Park, Lunts Heath Road, Widnes, Cheshire, WA8 5SQ.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention, modified to include the revaluation of freehold properties and to include investment properties and certain financial instruments at fair value. The principal accounting policies adopted are set out below.

1.2
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

 

 

Revenue from contracts for the provision of professional services is recognised by reference to the stage of completion when the stage of completion, costs incurred and costs to complete can be estimated reliably. The stage of completion is calculated by comparing costs incurred, mainly in relation to contractual hourly staff rates and materials, as a proportion of total costs. Where the outcome cannot be estimated reliably, revenue is recognised only to the extent of the expenses recognised that it is probable will be recovered.

1.3
Research and development expenditure

Research expenditure is written off against profits in the year in which it is incurred. Identifiable development expenditure is capitalised to the extent that the technical, commercial and financial feasibility can be demonstrated.

1.4
Intangible fixed assets other than goodwill

Intangible assets acquired separately from a business are recognised at cost and are subsequently measured at cost less accumulated amortisation and accumulated impairment losses.

 

Intangible assets acquired on business combinations are recognised separately from goodwill at the acquisition date where it is probable that the expected future economic benefits that are attributable to the asset will flow to the entity and the fair value of the asset can be measured reliably; the intangible asset arises from contractual or other legal rights; and the intangible asset is separable from the entity.

PATIENT PLAN DIRECT LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2020
1
Accounting policies
(Continued)
- 4 -

Amortisation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Software
20% Straight Line
Development Costs
20% Straight Line
1.5
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Fixtures and fittings
25% Straight Line
Computer equipment
20% Reducing Balance
Motor vehicles
25% Straight Line

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

 

1.6
Impairment of fixed assets

Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.

 

If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.

Recognised impairment losses are reversed if, and only if, the reasons for the impairment loss have ceased to apply. Where an impairment loss subsequently reverses, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognised for the asset (or cash-generating unit) in prior years. A reversal of an impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the reversal of the impairment loss is treated as a revaluation increase.

1.7
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

PATIENT PLAN DIRECT LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2020
1
Accounting policies
(Continued)
- 5 -
1.8
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

 

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

 

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

1.9
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.10
Derivatives

Derivatives are initially recognised at fair value at the date a derivative contract is entered into and are subsequently remeasured to fair value at each reporting end date. The resulting gain or loss is recognised in profit or loss immediately unless the derivative is designated and effective as a hedging instrument, in which event the timing of the recognition in profit or loss depends on the nature of the hedge relationship.

 

A derivative with a positive fair value is recognised as a financial asset, whereas a derivative with a negative fair value is recognised as a financial liability.

PATIENT PLAN DIRECT LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2020
1
Accounting policies
(Continued)
- 6 -
1.11
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

 

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

1.12
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

 

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

 

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

1.13
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

1.14
Leases

Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the leases asset are consumed.

1.15
Foreign exchange

Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation in the period are included in profit or loss.

PATIENT PLAN DIRECT LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2020
- 7 -
2
Judgements and key sources of estimation uncertainty

In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

 

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

3
Exceptional item
2020
2019
£
£
Income
Exceptional item
150,000
-
4
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2020
2019
Number
Number
Total
7
7
PATIENT PLAN DIRECT LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2020
- 8 -
5
Intangible fixed assets
Software
Development Costs
Total
£
£
£
Cost
At 1 January 2020
58,640
-
0
58,640
Additions - internally developed
59,008
-
0
59,008
Additions - separately acquired
-
0
116,569
116,569
Disposals
(6,400)
-
0
(6,400)
At 31 December 2020
111,248
116,569
227,817
Amortisation and impairment
At 1 January 2020
11,728
-
0
11,728
Amortisation charged for the year
17,461
13,055
30,516
Disposals
(1,280)
-
0
(1,280)
At 31 December 2020
27,909
13,055
40,964
Carrying amount
At 31 December 2020
83,339
103,514
186,853
At 31 December 2019
46,912
-
0
46,912
6
Tangible fixed assets
Fixtures and fittings
Computer equipment
Motor vehicles
Total
£
£
£
£
Cost
At 1 January 2020
33,935
26,559
7,000
67,494
Additions
-
0
1,633
-
0
1,633
At 31 December 2020
33,935
28,192
7,000
69,127
Depreciation and impairment
At 1 January 2020
9,169
16,265
1,750
27,184
Depreciation charged in the year
8,293
2,241
1,750
12,284
At 31 December 2020
17,462
18,506
3,500
39,468
Carrying amount
At 31 December 2020
16,473
9,686
3,500
29,659
At 31 December 2019
24,766
10,294
5,250
40,310
PATIENT PLAN DIRECT LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2020
- 9 -
7
Debtors
2020
2019
Amounts falling due within one year:
£
£
Trade debtors
21,664
13,055
Other debtors
23,035
19,668
44,699
32,723
8
Creditors: amounts falling due within one year
2020
2019
£
£
Bank loans and overdrafts
-
0
19,792
Trade creditors
15,921
39,260
Taxation and social security
102,862
41,264
Other creditors
118,396
28,297
237,179
128,613
9
Creditors: amounts falling due after more than one year
2020
2019
£
£
Bank loans and overdrafts
50,000
-
0
10
Operating lease commitments
Lessee

At the reporting end date the company had outstanding commitments for future minimum lease payments under non-cancellable operating leases, as follows:

2020
2019
£
£
121,134
157,114
PATIENT PLAN DIRECT LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2020
- 10 -
11
Parent company

The company is under the control of PPD Holdings Limited, a company registered in England and Wales, company number 10519195.

 

The registered office address is:

 

Glebe Business Park

Lunts Heath Road

Widnes

Cheshire

WA8 5SQ

2020-12-312020-01-01false06 September 2021CCH SoftwareCCH Accounts Production 2021.200No description of principal activityC BroadbentJ Woodall069054582020-01-012020-12-31069054582020-12-3106905458core:ComputerSoftware2020-12-3106905458core:DevelopmentCostsCapitalisedDevelopmentExpenditure2020-12-3106905458core:ComputerSoftware2019-12-3106905458core:DevelopmentCostsCapitalisedDevelopmentExpenditure2019-12-31069054582019-12-31069054582019-01-012019-12-3106905458core:FurnitureFittings2020-12-3106905458core:ComputerEquipment2020-12-3106905458core:MotorVehicles2020-12-3106905458core:FurnitureFittings2019-12-3106905458core:ComputerEquipment2019-12-3106905458core:MotorVehicles2019-12-3106905458core:CurrentFinancialInstrumentscore:WithinOneYear2020-12-3106905458core:CurrentFinancialInstrumentscore:WithinOneYear2019-12-3106905458core:Non-currentFinancialInstrumentscore:AfterOneYear2020-12-3106905458core:Non-currentFinancialInstrumentscore:AfterOneYear2019-12-3106905458core:CurrentFinancialInstruments2020-12-3106905458core:CurrentFinancialInstruments2019-12-3106905458core:ShareCapital2020-12-3106905458core:ShareCapital2019-12-3106905458core:RetainedEarningsAccumulatedLosses2020-12-3106905458core:RetainedEarningsAccumulatedLosses2019-12-3106905458bus:Director12020-01-012020-12-3106905458core:IntangibleAssetsOtherThanGoodwill2020-01-012020-12-3106905458core:ComputerSoftware2020-01-012020-12-3106905458core:DevelopmentCostsCapitalisedDevelopmentExpenditure2020-01-012020-12-3106905458core:FurnitureFittings2020-01-012020-12-3106905458core:ComputerEquipment2020-01-012020-12-3106905458core:MotorVehicles2020-01-012020-12-3106905458core:ComputerSoftware2019-12-3106905458core:DevelopmentCostsCapitalisedDevelopmentExpenditure2019-12-31069054582019-12-3106905458core:ComputerSoftwarecore:InternallyGeneratedIntangibleAssets2020-01-012020-12-3106905458core:DevelopmentCostsCapitalisedDevelopmentExpenditurecore:InternallyGeneratedIntangibleAssets2020-01-012020-12-3106905458core:InternallyGeneratedIntangibleAssets2020-01-012020-12-3106905458core:ComputerSoftwarecore:ExternallyAcquiredIntangibleAssets2020-01-012020-12-3106905458core:DevelopmentCostsCapitalisedDevelopmentExpenditurecore:ExternallyAcquiredIntangibleAssets2020-01-012020-12-3106905458core:ExternallyAcquiredIntangibleAssets2020-01-012020-12-3106905458core:FurnitureFittings2019-12-3106905458core:ComputerEquipment2019-12-3106905458core:MotorVehicles2019-12-3106905458core:WithinOneYear2020-12-3106905458core:WithinOneYear2019-12-3106905458core:Non-currentFinancialInstruments2020-12-3106905458core:Non-currentFinancialInstruments2019-12-3106905458bus:PrivateLimitedCompanyLtd2020-01-012020-12-3106905458bus:SmallCompaniesRegimeForAccounts2020-01-012020-12-3106905458bus:FRS1022020-01-012020-12-3106905458bus:AuditExemptWithAccountantsReport2020-01-012020-12-3106905458bus:Director22020-01-012020-12-3106905458bus:FullAccounts2020-01-012020-12-31xbrli:purexbrli:sharesiso4217:GBP